JN

Julfa Nasrin Laskar

Active Director Director DIN 11547638
DIN 11547638 First appointment Feb 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Julfa Nasrin Laskar

Data last updated:

Julfa Nasrin Laskar is a Director at Lihaaz Healthcare Private Limited (since 2026) and Director at Curelax Health Care Private Limited (since 2026).

DIN 11547638
Primary Designation Director
First Appointment 16 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lihaaz Healthcare Private Limited U86100AS2026PTC029980
Director24 Feb 20262026Active
Curelax Health Care Private Limited U86100AS2026PTC029907
Director16 Feb 20262026Active

Directorship timeline

Open interactive timeline →
Curelax Health Care Private Limited
Lihaaz Healthcare Private Limited
Premium access

Shareholding and investment profile for Julfa Nasrin Laskar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Julfa Nasrin Laskar

Julfa Nasrin Laskar currently holds 2 directorships: Lihaaz Healthcare Private Limited (Director, since 24 Feb 2026); Curelax Health Care Private Limited (Director, since 16 Feb 2026).

Julfa Nasrin Laskar was first appointed on 16 Feb 2026 as Director at Curelax Health Care Private Limited.

The current boards of Julfa Nasrin Laskar's companies include Ashif Ikbal (Lihaaz Healthcare Private Limited), Nishad Meher (Lihaaz Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available